Detalhe da pesquisa
1.
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
Mol Cancer
; 12: 16, 2013 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23452820
2.
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer.
Oncotarget
; 6(1): 56-70, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25474141
3.
Rapamycin rescues ABT-737 efficacy in small cell lung cancer.
Cancer Res
; 74(10): 2846-56, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24614082
4.
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer.
Mol Cancer Ther
; 12(6): 1131-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515613
5.
Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.
J Natl Cancer Inst
; 105(14): 1059-65, 2013 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23739064
6.
Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer.
Mol Cancer Res
; 11(4): 329-38, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23364532
7.
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer.
Cancer Res
; 71(21): 6764-72, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21896639
8.
Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.
Mol Cancer Res
; 9(12): 1746-54, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21994468
9.
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.
Cancer Res
; 68(7): 2321-8, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18381439